Integrating Data: Daiichi, Takeda Join Lifestyle Project To Inform R&D

Industry Has Called For Initiatives

The data collected from wearable devices for a year will provide lifecycle data to a much long-termed study with various health data. The study will not only contribute to drug discovery and personalized healthcare by the firms in near future, but also suggests bigger goals by Japan’s healthcare industry.

Study will use wearable device
Wearable devices will track lifecycles of 2,000 participants • Source: Shutterstock

Japanese research organization the Tohoku University Medical Megabank Organization (ToMMo), together with Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co. Ltd. and Japanese digital healthcare firm MICIN, have launched a joint research project that will use lifestyle data from around 2,000 people to inform a detailed analysis of how personal habits are related to health and disease. 

The project - forming part of Japanese pharma's wider ongoing efforts to mover "beyond the pill" - will combine the collected data on parameters such as heart rate, activity level and sleep status from wearable devices with health data from other cohort research, Daiichi stating the aim is to contribute to innovative medical research “such as drug discovery aimed at

More from Japan

More from Focus On Asia